FibroGen Inc (NASDAQ:FGEN)

10.80
Delayed Data
As of 4:14pm ET
 +0.065 / +0.61%
Today’s Change
9.89
Today|||52-Week Range
57.21
-70.88%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.1B

Company Description

FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993 and is headquartered in San Francisco, CA.

Contact Information

FibroGen, Inc.
409 Illinois Street
San Francisco California 94158
P:(415) 978-1200
Investor Relations:
(415) 978-1434

Employees

Shareholders

Mutual fund holders43.38%
Other institutional30.23%
Individual stakeholders15.03%

Top Executives

Enrique A. ConternoChief Executive Officer & Director
Juan GrahamChief Financial Officer
Michael MartinelliSenior Vice President-Technical Development
Elias KouchakjiSenior VP-Clinical Development & Drug Safety
Mark EisnerChief Medical Officer